MOREPENLAB Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > morepenlab

Technical Analysis

Technical Strength: 6.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 56.7. According to RSI analysis, morepenlab is technically strong. 9.0 MOREPENLAB RSI Chart
MACD (?) MACD: 1.72 and Signal Line: 1.94. According to MACD analysis, morepenlab is marginally weak. 3.0 MOREPENLAB MACD Chart
Simple Moving Average (?) According to simple moving average analysis, morepenlab is in a strong uptrend. Major support levels are 24.09, 20.155, 19.372. 10.0 MOREPENLAB Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, morepenlab is in a strong uptrend. Major support levels are 24.07396, 21.41914, 19.86533. 10.0 MOREPENLAB Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.55. 5.0 MOREPENLAB Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 23.7958 and 22.25. Resistance level is 28.8. 6.5 MOREPENLAB Fibonacci Retracement Chart
Average True Range (?) ATR: 1.59 NA MOREPENLAB Average True Range Chart
Average Directional Index (?) ADX is 49.7 which means MOREPENLAB is in a trend. NA MOREPENLAB Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
December 14, 2017
Open Price 25.2
High Price 25.6
Low Price 24.35
Close Price 24.6
Absolute Change -0.35
Percentage Change -1.4%
Weekly Change -11.4%
Monthly Change 27.8%
Yearly Change 11.3%
52-week high 28.8
52-week low 14.7
Corporate Actions
ExDate Purpose
September 14, 2017 ANNUAL GENERAL MEETING
September 11, 2014 Annual General Meeting
August 08, 2014 E - VOTING
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.935
Confidence in Beta2.29%
Market Capital Rs. 1106.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 0.34
TTM Price-to-Earnings (P/E) Ratio 72.4
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 14 December 2017: Deliverable Quantity:8.06e+05 NA MOREPENLAB Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 14 December 2017: Daily Volatility:0.8979 NA MOREPENLAB Annualized Daily Volatility (Spot Price) Chart

Announcements

November 13, 2017 Outcome of Board Meeting Morepen Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on November 10, 2017.
November 13, 2017 Press Release Morepen Laboratories Limited has informed the Exchange regarding a press release dated November 10, 2017, titled "Press Release release on the financial performance of the Company for the Quarter and Half-year ended 30th September, 2017".
See all Announcements

Board Meetings

Date Meeting Date Purpose
November 03, 2017 November 10, 2017 Results Inter-alia, to consider, approve and take on record the Un-audited Financial Results of the Company for the Quarter and Half-year ended September 30, 2017.
September 04, 2017 September 11, 2017 Results Inter-alia, to consider, approve and take on record the Un-audited Financial Results of the Company for the Quarter ended June 30, 2017.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 22.85 Rs. 23.6 Rs. 24.1 Rs. 24.85 Rs. 25.35 Rs. 26.1 Rs. 26.6